Cannabis-Based Dronabinol Could Transform Alzheimer’s Care, New Study Finds
October 6, 2024
An FDA-approved synthetic THC significantly reduces agitation in Alzheimer’s patients, improving treatment outcomes and caregiver relief.
Search
RECENT PRESS RELEASES
Related Post
